Skip to content

Svenningsson lab

Translational Research on Neuropharmacology and Movement Disorders

  • Home
  • News
  • Research
    • Pre-Clinical
      • P11 and G protein-coupled receptor function & pharmacology
      • Proteinopathies
    • Clinical
      • Clinical trials and Biomarkers in Parkinsonism
      • Ataxia, spastic paraparesis, chorea and other movement disorders
      • The role of glycemic control in Parkinson’s disease
  • Publications
  • People
    • Core Pre-Clinical Group
    • Core Clinical Group
    • Join our team
    • Alumni
    • Lab Group photos
  • Funding
  • Outreach
  • För Patienter
  • Contact
Posted on 23 June 2025 by Anderson Camargo

Meeting with OnoPharma

Per and Caterina, along with the OnoPharma group in London.

CategoriesUncategorized

Post navigation

Previous PostPrevious New paper in Movement Disorders regarding the effects of Montelukast on neuroinflammation in Parkinson’s Disease
Next PostNext Lab day at Skepparholmen

Postal Address

Karolinska Institutet
NKS, Bioclinicum
Visionsgatan 4
J5:20 Neuro- Svenningsson
Solna, 171 64

Telephone

+46 851774614

Our Karolinska Institute webpage

https://ki.se/en/cns/per-svenningssons-research-group-0

 

Proudly powered by WordPress